The OSI’s bold initiative brings a groundbreaking drug trial to osteosarcoma patients in record time.
Stories of Progress, Inspiration & Support
Research & Breakthroughs
Innovation and studies to improve patient outcomes
Optimism surrounds osteosarcoma research as the OSI awards $1.1 million in cancer research funding to three innovative projects.
How a girl’s love for her dog continues to live on in canine osteosarcoma research.
Troy A. McEachron, PhD, explores osteosarcoma’s interactions with its microenvironment and advocates for genetic diversity in research to ensure that findings are applicable to all populations.
Award-winning researcher explains how his work seeks to better understand osteosarcoma’s genomic instability to uncover novel treatments for the most aggressive types of the disease.
Osteosarcoma researcher Jason T. Yustein, MD, PhD, seeks to better understand the disease by testing various combinations of drugs to treat it.
Sign Up to Receive The Frontline
at vero eos et accusamus et iusto odio dignis simos duccimus qui blanditis
We never sell or share your information.
Your donation provides immediate and long-term support to osteosarcoma patients.